Allison Gatlin

PALMDALE — Pleased with the success of a license plate-reader camera system after a year of use, the City Council on Wednesday approved extending the contract with Flock Safety and increasing the number of cameras in the city by 50%.

Bristol Myers Squibb stock rocketed Monday after AbbVie's experimental schizophrenia treatment failed in a pair of midstage studies.

PALMDALE — New electric vehicle charging stations will be coming to three areas of Palmdale thanks to the city's share of a $14.8 million grant.

Neurogene tested its gene therapy in female patients with Rett syndrome.

AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, but AstraZeneca stock slipped amid a criminal probe in China.

AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China.

PALMDALE — Palmdale’s Tourism Improvement District, which provides the funding for Visit Palmdale, was renewed last week for more than nine years after the city received no opposition to the

Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space.

Amgen stock rebounded Wednesday, shaking off "overdone" fears that its monthly weight-loss shot causes excessive bone mineral density loss.

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.